Article info

PDF
Concise report
Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system

Authors

  1. Correspondence to Dr Peter M Izmirly, NYU School of Medicine, Hospital for Joint Diseases, 301 East 17th Street, Room 1611B, New York, NY 10003, USA; Peter.Izmirly{at}nyumc.org
View Full Text

Citation

Izmirly PM, Saxena A, Sahl SK, et al
Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system

Publication history

  • Received July 26, 2015
  • Revised October 22, 2015
  • Accepted November 7, 2015
  • First published December 1, 2015.
Online issue publication 
May 10, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.